[4-(1H-Tetrazol-1-yl)phenyl]acetic acid

CAS : 462068-57-1

Ref. 3D-FT116779

Informations sur le produit

• Nom: [4-(1H-Tetrazol-1-yl)phenyl]acetic acid
• Synonymes: [4-(1H-tetraazol-1-yl)phenyl]acetic acid, Benzeneacetic acid, 4-(1H-tetrazol-1-yl)-, [4-(1H-Tetrazol-1-yl)phenyl]acetic acid

Description

4-(1H-Tetrazol-1-yl)phenylacetic acid (PTZ) is a glucose-lowering drug that is structurally similar to an endogenous metabolite of glucose. It has been shown to have pharmacokinetic properties in animals and humans, highlighting the importance of the metabolic pathways in determining its pharmacokinetics. Pharmacokinetic profiling has also been conducted with transgenic animals and it has been shown to have agonistic properties. This drug discovery study has provided valuable information for future optimisation of this drug.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 204.19 g/mol
• Formule: C₉H₈N₄O₂
• Degré de pureté: Min. 95%
• InChI: InChI=1S/C9H8N4O2/c14-9(15)5-7-1-3-8(4-2-7)13-6-10-11-12-13/h1-4,6H,5H2,(H,14,15)
• Code InChI: InChIKey=OGYBWZMCGUWWHS-UHFFFAOYSA-N
• SMILES: O=C(O)Cc1ccc(-n2cnnn2)cc1